These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35233279)

  • 1. Pharmacists' Readiness to Receive, Recommend and Administer COVID-19 Vaccines in an African Country: An Online Multiple-Practice Settings Survey in Nigeria.
    Isah A; Ubaka CM
    Malawi Med J; 2021 Sep; 33(3):210-220. PubMed ID: 35233279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
    Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community acceptance and willingness to pay for hypothetical COVID-19 vaccines in a developing country: a web-based nationwide study in Nigeria.
    Okafor UG; Isah A; Onuh JC; Mgbemena CB; Ubaka CM
    Pan Afr Med J; 2021; 40():112. PubMed ID: 34887986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists as immunizers in Lebanon: a national survey of community pharmacists' willingness and readiness to administer adult immunization.
    Youssef D; Abou-Abbas L; Farhat S; Hassan H
    Hum Resour Health; 2021 Oct; 19(1):131. PubMed ID: 34689762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' Perceptions and Drivers of Immunization Practices for COVID-19 Vaccines: Results of a Nationwide Survey Prior to COVID-19 Vaccine Emergency Use Authorization.
    Jacob SS; Bridgeman MB; Kim H; Toscani M; Kohler R; Shiau S; Jimenez HR; Barone JA; Narayanan N
    Pharmacy (Basel); 2021 Jul; 9(3):. PubMed ID: 34449708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional questionnaire study of the experiences of community pharmacists in Northern Ireland during the early phases of the COVID-19 pandemic: preparation, experience and response.
    Patterson SM; Cadogan C; Barry HE; Bennett KE; Hughes C
    BMJ Open; 2022 Sep; 12(9):e064545. PubMed ID: 36137621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and Intentions of US Veterans Regarding COVID-19 Vaccination.
    Jasuja GK; Meterko M; Bradshaw LD; Carbonaro R; Clayman ML; LoBrutto L; Miano D; Maguire EM; Midboe AM; Asch SM; Gifford AL; McInnes DK; Elwy AR
    JAMA Netw Open; 2021 Nov; 4(11):e2132548. PubMed ID: 34730819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial.
    Curran G; Mosley C; Gamble A; Painter J; Ounpraseuth S; Brewer NT; Teeter B; Smith M; Halladay J; Hughes T; Shepherd JG; Hastings T; Simpson K; Carpenter D
    Implement Sci; 2023 Dec; 18(1):72. PubMed ID: 38110979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rural community pharmacists' ability and interest in administering COVID-19 vaccines in the Southern United States.
    Carpenter DM; Hastings T; Westrick S; Mashburn P; Rosenthal M; Smith M; Kiser S; Gamble A; Brewer NT; Curran G
    J Am Pharm Assoc (2003); 2022; 62(4):1379-1383. PubMed ID: 35221234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' readiness and willingness to vaccinate the public in United Arab Emirates community pharmacies: A cross-sectional study.
    Thomas D; Abdalla A; Hussein S; Joury J; Elshamy A; Khalifa S; Saleh Z
    F1000Res; 2023; 12():292. PubMed ID: 38774308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with Turkish pharmacists' intention to receive COVID-19 vaccine: an observational study.
    Okuyan B; Bektay MY; Demirci MY; Ay P; Sancar M
    Int J Clin Pharm; 2022 Feb; 44(1):247-255. PubMed ID: 34761359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.
    Ali Y; Piche-Renaud PP; Karimi-Shahrbabak E; Farrar DS; Fadaleh SA; Burey S; Morris SK
    Vaccine; 2023 May; 41(19):3058-3065. PubMed ID: 37045681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of the COVID-19 Vaccine and Willingness to Receive Vaccination among Health Workers in Nigeria: A Cross-sectional Study.
    Isiguzo GC; Stefanovics E; Unamba NN; Mbam TT; Anyaehie UG; Chukwu CC; Anyaehie UB; Osy-Eneze C; Ibezim EO; Okoro UG; Njoku PO; Adimekwe AI; Ibediro K; Stefanovics G; Iheanacho T
    Niger J Clin Pract; 2024 Jan; 27(1):102-108. PubMed ID: 38317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of COVID-19 vaccine hesitancy: questionnaire development and validation.
    Cvjetković S; Jeremić Stojković V; Piperac P; Djurdjević O; Bjegović-Mikanović V
    Cent Eur J Public Health; 2022 Jun; 30(2):99-106. PubMed ID: 35876598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia.
    Zammit N; Gueder AE; Brahem A; Ayouni I; Ghammam R; Fredj SB; Sridi C; Chouchene A; Kalboussi H; Maalel OE; Chatti S; Maatoug J; Ghannem H; Mrizak N
    BMC Health Serv Res; 2022 Apr; 22(1):489. PubMed ID: 35413911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population.
    Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K
    Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines.
    Doyno CR; Fitzgerald JM; White CM; Sobieraj DM; Zacchera M
    J Am Pharm Assoc (2003); 2022; 62(1):247-252. PubMed ID: 34462216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.